A Study for Evaluating Different Doses of Dexmedetomidine in Attenuating Extubation Response in Smoker Patients for Surgeries under General Anaesthesia
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 2 | Views: 294 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Comparative Studies | Anaesthesiology | India | Volume 11 Issue 1, January 2022 | Popularity: 5 / 10


     

A Study for Evaluating Different Doses of Dexmedetomidine in Attenuating Extubation Response in Smoker Patients for Surgeries under General Anaesthesia

Vivek Chaudhary


Abstract: Introduction: Smokers are one of the at-risk group of patients prone for developing complications during extubation. Objective: A study for evaluating different doses of dexmedetomidine in attenuating extubation response in smoker patients for surgeries under general anaesthesia. Study design: Prospective randomized study. Method: The present study was carried out and completed on ninety ASA II patients, aged between 40-60 years posted for surgery under general anaesthesia. Total 90 patients who fulfilled our inclusion and exclusion criteria were included in the study and divided randomly into three groups: Group A(n=30) 0.5?g/kg of dexmedetomidine in NS (Total volume 10 ml) Group B(n=30) 0.75?g/kg of dexmedetomidine in NS (Total volume 10 ml) Group C(n=30) 1?g/kg of dexmedetomidine in NS (Total volume 10 ml). Results: The difference in quality of extubation was significant between group A and group B and between group A and group C whereas it was comparable between group B and group C. Suggesting that extubation was better in group B and group C with dexmedetomidine dose 0.75 ?g/kg and 1 ?g/kg respectively. None of the patients had post-operative complications such as laryngospasm, bronchospasm, or severe coughing. None of the patient had respiratory depression. None of the patients had hypotension (MAP < 65 mmHg or more than 20% decrease in SBP from baseline value or SBP<80 mm of Hg). Conclusion: We conclude that dexmedetomidine with dose of 0.75 ?g/kg is the best dose for attenuation of extubation response in current smoker patients undergoing major surgery.


Keywords: Surgery, dexmedetomidine, extubation


Edition: Volume 11 Issue 1, January 2022


Pages: 1096 - 1099


DOI: https://www.doi.org/10.21275/MR22119203214


Please Disable the Pop-Up Blocker of Web Browser

Verification Code will appear in 2 Seconds ... Wait



Text copied to Clipboard!
Vivek Chaudhary, "A Study for Evaluating Different Doses of Dexmedetomidine in Attenuating Extubation Response in Smoker Patients for Surgeries under General Anaesthesia", International Journal of Science and Research (IJSR), Volume 11 Issue 1, January 2022, pp. 1096-1099, https://www.ijsr.net/getabstract.php?paperid=MR22119203214, DOI: https://www.doi.org/10.21275/MR22119203214

Top